Prosensa Holding BV (RNA)

[oldberkeley]

From this morning's earnings release:

We are currently working closely with GSK to transfer data and other elements covered in the collaboration as soon as practicable and within 120 days of the January 12 effective date of the agreement. Concurrently, we are focused on the continued analysis of the complete drisapersen data set, preparing for possible re-dosing of boys and having a meaningful dialogue with regulatory authorities. We expect to communicate the status of these events during the second quarter of this year.

http://ir.prosensa.eu/releasedetail.cfm?ReleaseID=833485